Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33616641.
- Also identified by DOI 10.1001/jamapediatrics.2020.6150 and PMC identifier 7900932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This randomized clinical trial examines the superiority of a single dose of rituximab vs low-dose mycophenolate mofetil in preventing the recurrence of steroid-dependent nephrotic syndrome in children and young adults.
Medical subject headings
- Enzyme Inhibitors
- Immunologic Factors
- Mycophenolic Acid
- Nephrotic Syndrome
- Rituximab